ACOG: Opioid agonist Rx first choice in affected pregnancies

July 28, 2017

(HealthDay)—While opioid agonist pharmacotherapy continues to be the recommended therapy for pregnant women with an opioid use disorder, medically supervised withdrawal can be considered under the care of a physician experienced in perinatal addiction treatment and with informed consent, according to a committee opinion published in the August issue of Obstetrics & Gynecology.

Maria A. Mascola, M.D., M.P.H., and colleagues from the American College of Obstetrics and Gynecology Committee on Obstetric Practice and the American Society of Addiction Medicine present ways to address opioid use in pregnancy, which has escalated dramatically in recent years.

The authors note that pregnancy offers an opportunity to identify and treat women with . Substance use screening should be universal, form part of comprehensive obstetric care, and be performed at the first prenatal visit. Opioid agonist pharmacotherapy is recommended for with opioid use disorder, and is preferable to medically supervised withdrawal. The authors note there may be a select group of women who make an informed choice of medically supervised withdrawal, which should be under the care of an experienced physician and include long-term follow-up and support to help prevent relapse. Pediatric care providers should monitor infants born to women who used opioids during pregnancy for neonatal abstinence withdrawal syndrome.

"Medication-assisted treatment improves adherence to prenatal care and and has been shown to reduce the risk of pregnancy complications," Mascola said in a statement.

Explore further: NIH-led workshop addresses opioid misuse during pregnancy

More information: Abstract/Full Text

Related Stories

NIH-led workshop addresses opioid misuse during pregnancy

June 9, 2017
Research is essential to determining how best to screen pregnant women for opioid use disorder, to treat pregnant women who have the disorder, and to care for infants as they experience withdrawal symptoms, according to experts ...

Opioid use disorder in pregnancy—Medication treatment improves outcomes for mothers and infants

April 14, 2017
Medication for addiction treatment (MAT) with buprenorphine or methadone is an appropriate and accepted treatment for pregnant women with opioid use disorder (OUD), according to a research review and update in the Journal ...

Clinical trial looks at tramadol for opioid withdrawal

July 12, 2017
A randomized clinical trial published by JAMA Psychiatry compared tramadol extended-release with clonidine and buprenorphine for the management of opioid withdrawal symptoms in patients with opioid use disorder in a residential ...

Don't punish pregnant women for opioid use, docs say

February 20, 2017
(HealthDay)—Prevention and treatment, not legal action, should be the focus when dealing with pregnant women who use opioids, a leading pediatricians' group says.

New study reveals some women with prenatal opioid dependence are not being treated

April 5, 2017
A new study by Queen's University researcher Susan Brogly (Surgery) has revealed that 25 per cent of women suffering from a prenatal opioid dependence were not being treated for their addiction. Using data from the Institute ...

Treating infants of mothers with opioid dependence—rising rates, rising costs

May 19, 2015
As more infants are born to mothers with dependence on prescription pain medications, the costs of treatment for babies with neonatal abstinence syndrome (NAS) have increased dramatically, suggests a report in the March/April ...

Recommended for you

New study reveals time and day women are most likely to give birth

June 15, 2018
A new study has found that the time and day that women give birth can vary significantly depending on how labour starts and the mode of giving birth.

Blood test for pregnant women can predict premature birth

June 7, 2018
A new blood test for pregnant women detects with 75-80 percent accuracy whether their pregnancies will end in premature birth. The technique can also be used to estimate a fetus's gestational age—or the mother's due date—as ...

Drug combination offers more effective care for patients suffering miscarriage

June 6, 2018
A combination of the drugs mifepristone and misoprostol can help bring closure to some women and their families suffering from miscarriage, and reduces the need for surgical intervention to complete the painful miscarriage ...

Genes, environment and schizophrenia—new study finds the placenta is the missing link

May 28, 2018
Hiding in plain sight, new research shines a spotlight on the placenta's critical role in the nature versus nurture debate and how it confers risk for schizophrenia and likely other neurodevelopmental disorders including ...

Vendors say pot eases morning sickness. Will baby pay a price?

May 22, 2018
(HealthDay)—Nearly 70 percent of Colorado marijuana dispensaries recommended pot products to manage early pregnancy-related morning sickness, new research reveals.

Pregnancy drug DES might have triggered ADHD in the grandchildren of women who used it

May 21, 2018
A study conducted by researchers at Columbia University's Mailman School of Public Health and Harvard T.H. Chan School of Public Health reported elevated odds for attention deficit hyperactivity disorder (ADHD) in the grandchildren ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.